Phase II trial of vorinostat with idarubicin and cytarabine for patients with newly diagnosed acute myelogenous leukemia or myelodysplastic syndrome.
暂无分享，去创建一个
M. Konopleva | H. Kantarjian | G. Garcia-Manero | J. Cortes | T. Kadia | F. Ravandi | G. Borthakur | E. Jabbour | S. Pierce | F. Tambaro | Hui Yang | M. de Lima | S. Faderl | Yumin Hu | M. Brandt | N. Bekele | Deborah McCue | W. Newsome | Nebiyou B. Bekele | Deborah Mccue | F. P. Tambaro